ID   SCN2A_RAT               Reviewed;        2005 AA.
AC   P04775;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   24-JAN-2024, entry version 185.
DE   RecName: Full=Sodium channel protein type 2 subunit alpha {ECO:0000305};
DE   AltName: Full=Sodium channel protein brain II subunit alpha;
DE   AltName: Full=Sodium channel protein type II subunit alpha;
DE   AltName: Full=Voltage-gated sodium channel subunit alpha Nav1.2;
GN   Name=Scn2a {ECO:0000312|RGD:3632}; Synonyms=Scn2a1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3754035; DOI=10.1038/320188a0;
RA   Noda M., Ikeda T., Kayano T., Suzuki H., Takeshima H., Kurasaki M.,
RA   Takahashi H., Numa S.;
RT   "Existence of distinct sodium channel messenger RNAs in rat brain.";
RL   Nature 320:188-192(1986).
RN   [2]
RP   PHOSPHORYLATION AT SER-1506, AND MUTAGENESIS OF SER-1506.
RX   PubMed=1658937; DOI=10.1126/science.1658937;
RA   West J.W., Numann R., Murphy B.J., Scheuer T., Catterall W.A.;
RT   "A phosphorylation site in the Na+ channel required for modulation by
RT   protein kinase C.";
RL   Science 254:866-868(1991).
RN   [3]
RP   PHOSPHORYLATION AT SER-554; SER-573; SER-576 AND SER-1506.
RX   PubMed=1322892; DOI=10.1016/s0021-9258(18)41976-x;
RA   Murphy B.J., Catterall W.A.;
RT   "Phosphorylation of purified rat brain Na+ channel reconstituted into
RT   phospholipid vesicles by protein kinase C.";
RL   J. Biol. Chem. 267:16129-16134(1992).
RN   [4]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=10827969; DOI=10.1016/s0006-3495(00)76829-9;
RA   Planells-Cases R., Caprini M., Zhang J., Rockenstein E.M., Rivera R.R.,
RA   Murre C., Masliah E., Montal M.;
RT   "Neuronal death and perinatal lethality in voltage-gated sodium channel
RT   alpha(II)-deficient mice.";
RL   Biophys. J. 78:2878-2891(2000).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF 879-GLY--LEU-881.
RX   PubMed=11166117; DOI=10.1016/s0306-4522(00)00479-6;
RA   Kearney J.A., Plummer N.W., Smith M.R., Kapur J., Cummins T.R.,
RA   Waxman S.G., Goldin A.L., Meisler M.H.;
RT   "A gain-of-function mutation in the sodium channel gene Scn2a results in
RT   seizures and behavioral abnormalities.";
RL   Neuroscience 102:307-317(2001).
RN   [6]
RP   INTERACTION WITH NEDD4L, POSSIBLE UBIQUITINATION, AND MUTAGENESIS OF
RP   TYR-1975.
RX   PubMed=15548568; DOI=10.1152/ajpcell.00460.2004;
RA   Rougier J.-S., van Bemmelen M.X., Bruce M.C., Jespersen T., Gavillet B.,
RA   Apotheloz F., Cordonier S., Staub O., Rotin D., Abriel H.;
RT   "Molecular determinants of voltage-gated sodium channel regulation by the
RT   Nedd4/Nedd4-like proteins.";
RL   Am. J. Physiol. 288:C692-C701(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1963, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [8]
RP   INTERACTION WITH SCORPION TOXIN BMK M1, AND MUTAGENESIS OF GLU-1613.
RX   PubMed=20678086; DOI=10.1042/bj20100517;
RA   He H., Liu Z., Dong B., Zhou J., Zhu H., Ji Y.;
RT   "Molecular determination of selectivity of the site 3 modulator (BmK I) to
RT   sodium channels in the CNS: a clue to the importance of Nav1.6 in BmK I-
RT   induced neuronal hyperexcitability.";
RL   Biochem. J. 431:289-298(2010).
RN   [9]
RP   PHOSPHORYLATION AT SER-4; SER-468; SER-471; SER-484; SER-528; SER-554;
RP   SER-610; SER-623; SER-687; SER-688; SER-721; SER-1930; THR-1966 AND
RP   SER-1971.
RX   PubMed=20131913; DOI=10.1021/pr901171q;
RA   Berendt F.J., Park K.S., Trimmer J.S.;
RT   "Multisite phosphorylation of voltage-gated sodium channel alpha subunits
RT   from rat brain.";
RL   J. Proteome Res. 9:1976-1984(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-484; SER-526; SER-528;
RP   SER-531; SER-553; SER-554; SER-558; SER-589; SER-721 AND THR-1943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [11]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR LOCATION, SUBUNIT, DISULFIDE
RP   BOND, AND INTERACTION WITH SCN4B.
RX   PubMed=24297919; DOI=10.1073/pnas.1314557110;
RA   Gilchrist J., Das S., Van Petegem F., Bosmans F.;
RT   "Crystallographic insights into sodium-channel modulation by the beta4
RT   subunit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:E5016-E5024(2013).
RN   [12]
RP   MUTAGENESIS OF CYS-910, INTERACTION WITH THE CONOTOXIN GVIIJ, AND DISULFIDE
RP   BOND.
RX   PubMed=24497506; DOI=10.1073/pnas.1324189111;
RA   Gajewiak J., Azam L., Imperial J., Walewska A., Green B.R.,
RA   Bandyopadhyay P.K., Raghuraman S., Ueberheide B., Bern M., Zhou H.M.,
RA   Minassian N.A., Hagan R.H., Flinspach M., Liu Y., Bulaj G., Wickenden A.D.,
RA   Olivera B.M., Yoshikami D., Zhang M.M.;
RT   "A disulfide tether stabilizes the block of sodium channels by the
RT   conotoxin muO[section sign]-GVIIJ.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:2758-2763(2014).
RN   [13]
RP   MUTAGENESIS OF PHE-385.
RX   PubMed=26039939; DOI=10.1021/acs.biochem.5b00390;
RA   Zhang M.M., Gajewiak J., Azam L., Bulaj G., Olivera B.M., Yoshikami D.;
RT   "Probing the redox states of sodium channel cysteines at the binding site
RT   of muO[section sign]-conotoxin GVIIJ.";
RL   Biochemistry 54:3911-3920(2015).
RN   [14]
RP   STRUCTURE BY NMR OF 1474-1526, FUNCTION, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF PHE-1489.
RX   PubMed=9893979; DOI=10.1021/bi9823380;
RA   Rohl C.A., Boeckman F.A., Baker C., Scheuer T., Catterall W.A.,
RA   Klevit R.E.;
RT   "Solution structure of the sodium channel inactivation gate.";
RL   Biochemistry 38:855-861(1999).
RN   [15]
RP   STRUCTURE BY NMR OF 1901-1927 IN COMPLEX WITH CALM, AND INTERACTION WITH
RP   CALM.
RX   PubMed=21439835; DOI=10.1016/j.str.2011.02.009;
RA   Feldkamp M.D., Yu L., Shea M.A.;
RT   "Structural and energetic determinants of apo calmodulin binding to the IQ
RT   motif of the Na(V)1.2 voltage-dependent sodium channel.";
RL   Structure 19:733-747(2011).
RN   [16]
RP   SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=26894959; DOI=10.7554/elife.10960;
RA   Das S., Gilchrist J., Bosmans F., Van Petegem F.;
RT   "Binary architecture of the Nav1.2-beta2 signaling complex.";
RL   Elife 5:0-0(2016).
RN   [17]
RP   FUNCTION, TRANSPORTER ACTIVITY, SUMOYLATION AT LYS-38, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF LYS-38.
RX   PubMed=28029095; DOI=10.7554/elife.20054;
RA   Plant L.D., Marks J.D., Goldstein S.A.;
RT   "SUMOylation of NaV1.2 channels mediates the early response to acute
RT   hypoxia in central neurons.";
RL   Elife 5:0-0(2016).
CC   -!- FUNCTION: Mediates the voltage-dependent sodium ion permeability of
CC       excitable membranes. Assuming opened or closed conformations in
CC       response to the voltage difference across the membrane, the protein
CC       forms a sodium-selective channel through which Na(+) ions may pass in
CC       accordance with their electrochemical gradient. Implicated in the
CC       regulation of hippocampal replay occurring within sharp wave ripples
CC       (SPW-R) important for memory (By similarity).
CC       {ECO:0000250|UniProtKB:B1AWN6, ECO:0000269|PubMed:24297919,
CC       ECO:0000269|PubMed:28029095, ECO:0000269|PubMed:9893979}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Na(+)(in) = Na(+)(out); Xref=Rhea:RHEA:34963,
CC         ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:24297919,
CC         ECO:0000269|PubMed:28029095};
CC   -!- SUBUNIT: Heterooligomer of a large alpha subunit and a smaller beta
CC       subunit. Heterooligomer with SCN2B or SCN4B; disulfide-linked
CC       (PubMed:26894959). Heterooligomer with SCN1B or SCN3B; non-covalently
CC       linked. Interacts with NEDD4L. Interacts with CALM. Interacts with
CC       TMEM233 (By similarity). Interacts with the conotoxin GVIIJ
CC       (PubMed:24497506). Interacts with the scorpion toxin BMK M1
CC       (PubMed:20678086). {ECO:0000250|UniProtKB:Q99250,
CC       ECO:0000269|PubMed:15548568, ECO:0000269|PubMed:21439835,
CC       ECO:0000269|PubMed:24297919, ECO:0000269|PubMed:24497506,
CC       ECO:0000269|PubMed:26894959}.
CC   -!- INTERACTION:
CC       P04775; P21707: Syt1; NbExp=2; IntAct=EBI-2619448, EBI-458098;
CC       P04775; P07463: CAM; Xeno; NbExp=2; IntAct=EBI-2619448, EBI-15916571;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10827969,
CC       ECO:0000269|PubMed:24297919, ECO:0000269|PubMed:28029095,
CC       ECO:0000269|PubMed:9893979}; Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in brain (at protein level)
CC       (PubMed:10827969). Expressed in cerebellar granule neurons (at protein
CC       level) (PubMed:28029095). {ECO:0000269|PubMed:10827969,
CC       ECO:0000269|PubMed:28029095}.
CC   -!- DOMAIN: The sequence contains 4 internal repeats, each with 5
CC       hydrophobic segments (S1, S2, S3, S5, S6) and one positively charged
CC       segment (S4). Segments S4 are probably the voltage-sensors and are
CC       characterized by a series of positively charged amino acids at every
CC       third position. {ECO:0000305}.
CC   -!- PTM: May be ubiquitinated by NEDD4L; which would promote its
CC       endocytosis.
CC   -!- PTM: Phosphorylation at Ser-1506 by PKC in a highly conserved
CC       cytoplasmic loop slows inactivation of the sodium channel and reduces
CC       peak sodium currents. {ECO:0000269|PubMed:1322892,
CC       ECO:0000269|PubMed:1658937, ECO:0000269|PubMed:20131913}.
CC   -!- PTM: Sumoylated at Lys-38. Sumoylation is induced by hypoxia, increases
CC       voltage-gated sodium current and mediates the early response to acute
CC       hypoxia in neurons (PubMed:28029095). Sumoylated SCN2A is located at
CC       the cell membrane (PubMed:28029095). {ECO:0000269|PubMed:28029095}.
CC   -!- SIMILARITY: Belongs to the sodium channel (TC 1.A.1.10) family.
CC       Nav1.2/SCN2A subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X03639; CAA27287.1; -; mRNA.
DR   RefSeq; NP_036779.1; NM_012647.1.
DR   PDB; 1BYY; NMR; -; A=1474-1526.
DR   PDB; 2KXW; NMR; -; B=1901-1927.
DR   PDB; 2M5E; NMR; -; B=1901-1927.
DR   PDBsum; 1BYY; -.
DR   PDBsum; 2KXW; -.
DR   PDBsum; 2M5E; -.
DR   AlphaFoldDB; P04775; -.
DR   BMRB; P04775; -.
DR   SMR; P04775; -.
DR   BioGRID; 246890; 6.
DR   CORUM; P04775; -.
DR   DIP; DIP-57088N; -.
DR   IntAct; P04775; 2.
DR   STRING; 10116.ENSRNOP00000007069; -.
DR   BindingDB; P04775; -.
DR   ChEMBL; CHEMBL3399; -.
DR   DrugCentral; P04775; -.
DR   GuidetoPHARMACOLOGY; 579; -.
DR   GlyCosmos; P04775; 10 sites, No reported glycans.
DR   GlyGen; P04775; 10 sites.
DR   iPTMnet; P04775; -.
DR   PhosphoSitePlus; P04775; -.
DR   SwissPalm; P04775; -.
DR   PaxDb; 10116-ENSRNOP00000007069; -.
DR   ABCD; P04775; 1 sequenced antibody.
DR   GeneID; 24766; -.
DR   KEGG; rno:24766; -.
DR   UCSC; RGD:3632; rat.
DR   AGR; RGD:3632; -.
DR   CTD; 6326; -.
DR   RGD; 3632; Scn2a.
DR   eggNOG; KOG2301; Eukaryota.
DR   InParanoid; P04775; -.
DR   OrthoDB; 1110761at2759; -.
DR   PhylomeDB; P04775; -.
DR   EvolutionaryTrace; P04775; -.
DR   PRO; PR:P04775; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0043194; C:axon initial segment; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0014704; C:intercalated disc; ISO:RGD.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0033268; C:node of Ranvier; IDA:BHF-UCL.
DR   GO; GO:0033270; C:paranode region of axon; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0030315; C:T-tubule; ISO:RGD.
DR   GO; GO:0001518; C:voltage-gated sodium channel complex; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISO:RGD.
DR   GO; GO:0043522; F:leucine zipper domain binding; IPI:RGD.
DR   GO; GO:0031402; F:sodium ion binding; IDA:RGD.
DR   GO; GO:0099508; F:voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0005248; F:voltage-gated sodium channel activity; IDA:UniProtKB.
DR   GO; GO:0061564; P:axon development; IEP:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0021987; P:cerebral cortex development; IEP:RGD.
DR   GO; GO:0022038; P:corpus callosum development; IEP:RGD.
DR   GO; GO:0021542; P:dentate gyrus development; ISO:RGD.
DR   GO; GO:0008340; P:determination of adult lifespan; ISO:RGD.
DR   GO; GO:0008627; P:intrinsic apoptotic signaling pathway in response to osmotic stress; ISS:UniProtKB.
DR   GO; GO:0086010; P:membrane depolarization during action potential; IBA:GO_Central.
DR   GO; GO:0007613; P:memory; ISS:UniProtKB.
DR   GO; GO:0042552; P:myelination; IEP:BHF-UCL.
DR   GO; GO:0021675; P:nerve development; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0051402; P:neuron apoptotic process; ISS:UniProtKB.
DR   GO; GO:0019228; P:neuronal action potential; IDA:UniProtKB.
DR   GO; GO:0021554; P:optic nerve development; IEP:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006814; P:sodium ion transport; IDA:RGD.
DR   CDD; cd13433; Na_channel_gate; 1.
DR   DisProt; DP02624; -.
DR   Gene3D; 1.10.287.70; -; 4.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 1.20.5.1190; iswi atpase; 1.
DR   Gene3D; 1.20.120.350; Voltage-gated potassium channels. Chain C; 4.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR001696; Na_channel_asu.
DR   InterPro; IPR044564; Na_chnl_inactivation_gate.
DR   InterPro; IPR010526; Na_trans_assoc_dom.
DR   InterPro; IPR024583; Na_trans_cytopl.
DR   InterPro; IPR043203; VGCC_Ca_Na.
DR   InterPro; IPR027359; Volt_channel_dom_sf.
DR   PANTHER; PTHR10037:SF278; SODIUM CHANNEL PROTEIN TYPE 2 SUBUNIT ALPHA; 1.
DR   PANTHER; PTHR10037; VOLTAGE-GATED CATION CHANNEL CALCIUM AND SODIUM; 1.
DR   Pfam; PF00520; Ion_trans; 4.
DR   Pfam; PF06512; Na_trans_assoc; 1.
DR   Pfam; PF11933; Na_trans_cytopl; 1.
DR   PRINTS; PR00170; NACHANNEL.
DR   SMART; SM00015; IQ; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 4.
DR   PROSITE; PS50096; IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Isopeptide bond; Membrane; Phosphoprotein;
KW   Reference proteome; Repeat; Sodium; Sodium channel; Sodium transport;
KW   Transmembrane; Transmembrane helix; Transport; Ubl conjugation;
KW   Voltage-gated channel.
FT   CHAIN           1..2005
FT                   /note="Sodium channel protein type 2 subunit alpha"
FT                   /id="PRO_0000048492"
FT   TOPO_DOM        1..129
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        130..148
FT                   /note="Helical; Name=S1 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        149..155
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        156..176
FT                   /note="Helical; Name=S2 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        177..190
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        191..208
FT                   /note="Helical; Name=S3 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        209..214
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        215..231
FT                   /note="Helical; Name=S4 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        232..250
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        251..270
FT                   /note="Helical; Name=S5 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        271..369
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        370..394
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        395..401
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        402..422
FT                   /note="Helical; Name=S6 of repeat I"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        423..759
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        760..778
FT                   /note="Helical; Name=S1 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        779..789
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        790..809
FT                   /note="Helical; Name=S2 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        810..823
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        824..843
FT                   /note="Helical; Name=S3 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        844..845
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        846..863
FT                   /note="Helical; Name=S4 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        864..879
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        880..898
FT                   /note="Helical; Name=S5 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        899..927
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        928..948
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        949..961
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        962..982
FT                   /note="Helical; Name=S6 of repeat II"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        983..1209
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1210..1227
FT                   /note="Helical; Name=S1 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1228..1240
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1241..1259
FT                   /note="Helical; Name=S2 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1260..1273
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1274..1292
FT                   /note="Helical; Name=S3 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1293..1300
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1301..1319
FT                   /note="Helical; Name=S4 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1320..1336
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1337..1356
FT                   /note="Helical; Name=S5 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1357..1408
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1409..1430
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1431..1447
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1448..1469
FT                   /note="Helical; Name=S6 of repeat III"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1470..1532
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1533..1550
FT                   /note="Helical; Name=S1 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1551..1561
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1562..1580
FT                   /note="Helical; Name=S2 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1581..1592
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1593..1610
FT                   /note="Helical; Name=S3 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1611..1623
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1624..1640
FT                   /note="Helical; Name=S4 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1641..1659
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1660..1677
FT                   /note="Helical; Name=S5 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1678..1699
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   INTRAMEM        1700..1722
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1723..1752
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1753..1775
FT                   /note="Helical; Name=S6 of repeat IV"
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   TOPO_DOM        1776..2005
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REPEAT          111..456
FT                   /note="I"
FT                   /evidence="ECO:0000305"
FT   REPEAT          741..1013
FT                   /note="II"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1190..1504
FT                   /note="III"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1513..1811
FT                   /note="IV"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          1905..1934
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   REGION          28..61
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          494..529
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          591..634
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          917..918
FT                   /note="Binds SCN2B"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   REGION          1120..1166
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1933..2005
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        28..53
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        510..529
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        591..623
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1933..1959
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1960..1977
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1978..2005
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            330
FT                   /note="Binds Mu-conotoxin KIIIA"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            362
FT                   /note="Binds Mu-conotoxin KIIIA"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            909
FT                   /note="Binds SCN2B; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            916
FT                   /note="Binds Mu-conotoxin KIIIA; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            920
FT                   /note="Binds Mu-conotoxin KIIIA; via carbonyl oxygen"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            945
FT                   /note="Binds Mu-conotoxin KIIIA"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            949
FT                   /note="Binds Mu-conotoxin KIIIA"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            1374
FT                   /note="Binds Mu-conotoxin KIIIA; via amide nitrogen"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            1429
FT                   /note="Binds Mu-conotoxin KIIIA"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            1443
FT                   /note="Binds Mu-conotoxin KIIIA"
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   SITE            1489
FT                   /note="Important for channel closure"
FT   MOD_RES         4
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         468
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         471
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         526
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         528
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         531
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         553
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         554
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:1322892,
FT                   ECO:0000269|PubMed:20131913, ECO:0007744|PubMed:22673903"
FT   MOD_RES         554
FT                   /note="Phosphoserine; by PKC; in vitro"
FT                   /evidence="ECO:0000269|PubMed:1322892,
FT                   ECO:0000269|PubMed:20131913, ECO:0007744|PubMed:22673903"
FT   MOD_RES         558
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         573
FT                   /note="Phosphoserine; by PKC; in vitro"
FT                   /evidence="ECO:0000269|PubMed:1322892"
FT   MOD_RES         576
FT                   /note="Phosphoserine; by PKC; in vitro"
FT                   /evidence="ECO:0000269|PubMed:1322892"
FT   MOD_RES         589
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         610
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         623
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         687
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         688
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         721
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         1506
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:1322892,
FT                   ECO:0000269|PubMed:1658937"
FT   MOD_RES         1930
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         1943
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1963
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         1966
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   MOD_RES         1971
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20131913"
FT   CARBOHYD        212
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        285
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        291
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        303
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        308
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        340
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1368
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1393
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        278..338
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   DISULFID        910
FT                   /note="Interchain; with SCN2B or SCN4B"
FT                   /evidence="ECO:0000269|PubMed:26894959,
FT                   ECO:0000305|PubMed:24497506"
FT   DISULFID        910
FT                   /note="Interchain; with the conotoxin GVIIJ (when the
FT                   channel is not linked to SCN2B or SCN4B; the bond to SCN2B
FT                   or SCN4B protects the channel from the inhibition by
FT                   toxin)"
FT                   /evidence="ECO:0000269|PubMed:24497506"
FT   DISULFID        912..918
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   DISULFID        950..959
FT                   /evidence="ECO:0000250|UniProtKB:D0E0C2"
FT   DISULFID        1366..1386
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   DISULFID        1731..1746
FT                   /evidence="ECO:0000250|UniProtKB:Q99250"
FT   CROSSLNK        38
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000269|PubMed:28029095"
FT   MUTAGEN         38
FT                   /note="K->Q: Abolishes SUMOylation. No increase of voltage-
FT                   gated sodium current upon hypoxia."
FT                   /evidence="ECO:0000269|PubMed:28029095"
FT   MUTAGEN         385
FT                   /note="F->C: Sodium current is irreversibly blocked by
FT                   methanethiosulfonate (MTSET); the mutated Cys residue has a
FT                   free thiol susceptible to reaction with MTSET, and
FT                   inhibition of current is due to the fact that the residue
FT                   is close to the selectivity filter."
FT                   /evidence="ECO:0000250|UniProtKB:P15389,
FT                   ECO:0000269|PubMed:26039939"
FT   MUTAGEN         879..881
FT                   /note="GAL->QQQ: Slowed inactivation and increased
FT                   persistent current. Gain of function mutation."
FT                   /evidence="ECO:0000269|PubMed:11166117"
FT   MUTAGEN         910
FT                   /note="C->L: >1000-fold reduction of sensitivity to the
FT                   conotoxin GVIIJ(SSG)."
FT                   /evidence="ECO:0000269|PubMed:24497506"
FT   MUTAGEN         1489
FT                   /note="F->Q: Strongly impairs channel inactivation."
FT                   /evidence="ECO:0000269|PubMed:9893979"
FT   MUTAGEN         1506
FT                   /note="S->A: Blocks the reduction of Na+ current and the
FT                   slowing of inactivation caused by PKC."
FT                   /evidence="ECO:0000269|PubMed:1658937"
FT   MUTAGEN         1613
FT                   /note="E->D: Increase in sensitivity to the scorpion toxin
FT                   BMK M1."
FT                   /evidence="ECO:0000269|PubMed:20678086"
FT   MUTAGEN         1975
FT                   /note="Y->A: Abolishes interaction with NEDD4L."
FT                   /evidence="ECO:0000269|PubMed:15548568"
FT   HELIX           1492..1502
FT                   /evidence="ECO:0007829|PDB:1BYY"
FT   HELIX           1904..1922
FT                   /evidence="ECO:0007829|PDB:2KXW"
SQ   SEQUENCE   2005 AA;  227874 MW;  861BE583D79F8324 CRC64;
     MARSVLVPPG PDSFRFFTRE SLAAIEQRIA EEKAKRPKQE RKDEDDENGP KPNSDLEAGK
     SLPFIYGDIP PEMVSEPLED LDPYYINKKT FIVLNKGKAI SRFSATSALY ILTPFNPIRK
     LAIKILVHSL FNVLIMCTIL TNCVFMTMSN PPDWTKNVEY TFTGIYTFES LIKILARGFC
     LEDFTFLRNP WNWLDFTVIT FAYVTEFVNL GNVSALRTFR VLRALKTISV IPGLKTIVGA
     LIQSVKKLSD VMILTVFCLS VFALIGLQLF MGNLRNKCLQ WPPDNSTFEI NITSFFNNSL
     DWNGTAFNRT VNMFNWDEYI EDKSHFYFLE GQNDALLCGN SSDAGQCPEG YICVKAGRNP
     NYGYTSFDTF SWAFLSLFRL MTQDFWENLY QLTLRAAGKT YMIFFVLVIF LGSFYLINLI
     LAVVAMAYEE QNQATLEEAE QKEAEFQQML EQLKKQQEEA QAAAAAASAE SRDFSGAGGI
     GVFSESSSVA SKLSSKSEKE LKNRRKKKKQ KEQAGEEEKE DAVRKSASED SIRKKGFQFS
     LEGSRLTYEK RFSSPHQSLL SIRGSLFSPR RNSRASLFNF KGRVKDIGSE NDFADDEHST
     FEDNDSRRDS LFVPHRHGER RPSNVSQASR ASRGIPTLPM NGKMHSAVDC NGVVSLVGGP
     SALTSPVGQL LPEGTTTETE IRKRRSSSYH VSMDLLEDPS RQRAMSMASI LTNTMEELEE
     SRQKCPPCWY KFANMCLIWD CCKPWLKVKH VVNLVVMDPF VDLAITICIV LNTLFMAMEH
     YPMTEQFSSV LSVGNLVFTG IFTAEMFLKI IAMDPYYYFQ EGWNIFDGFI VSLSLMELGL
     ANVEGLSVLR SFRLLRVFKL AKSWPTLNML IKIIGNSVGA LGNLTLVLAI IVFIFAVVGM
     QLFGKSYKEC VCKISNDCEL PRWHMHHFFH SFLIVFRVLC GEWIETMWDC MEVAGQTMCL
     TVFMMVMVIG NLVVLNLFLA LLLSSFSSDN LAATDDDNEM NNLQIAVGRM QKGIDFVKRK
     IREFIQKAFV RKQKALDEIK PLEDLNNKKD SCISNHTTIE IGKDLNYLKD GNGTTSGIGS
     SVEKYVVDES DYMSFINNPS LTVTVPIALG ESDFENLNTE EFSSESDMEE SKEKLNATSS
     SEGSTVDIGA PAEGEQPEAE PEESLEPEAC FTEDCVRKFK CCQISIEEGK GKLWWNLRKT
     CYKIVEHNWF ETFIVFMILL SSGALAFEDI YIEQRKTIKT MLEYADKVFT YIFILEMLLK
     WVAYGFQMYF TNAWCWLDFL IVDVSLVSLT ANALGYSELG AIKSLRTLRA LRPLRALSRF
     EGMRVVVNAL LGAIPSIMNV LLVCLIFWLI FSIMGVNLFA GKFYHCINYT TGEMFDVSVV
     NNYSECQALI ESNQTARWKN VKVNFDNVGL GYLSLLQVAT FKGWMDIMYA AVDSRNVELQ
     PKYEDNLYMY LYFVIFIIFG SFFTLNLFIG VIIDNFNQQK KKFGGQDIFM TEEQKKYYNA
     MKKLGSKKPQ KPIPRPANKF QGMVFDFVTK QVFDISIMIL ICLNMVTMMV ETDDQSQEMT
     NILYWINLVF IVLFTGECVL KLISLRHYYF TIGWNIFDFV VVILSIVGMF LAELIEKYFV
     SPTLFRVIRL ARIGRILRLI KGAKGIRTLL FALMMSLPAL FNIGLLLFLV MFIYAIFGMS
     NFAYVKREVG IDDMFNFETF GNSMICLFQI TTSAGWDGLL APILNSGPPD CDPEKDHPGS
     SVKGDCGNPS VGIFFFVSYI IISFLVVVNM YIAVILENFS VATEESAEPL SEDDFEMFYE
     VWEKFDPDAT QFIEFCKLSD FAAALDPPLL IAKPNKVQLI AMDLPMVSGD RIHCLDILFA
     FTKRVLGESG EMDALRIQME ERFMASNPSK VSYEPITTTL KRKQEEVSAI VIQRAYRRYL
     LKQKVKKVSS IYKKDKGKED EGTPIKEDII TDKLNENSTP EKTDVTPSTT SPPSYDSVTK
     PEKEKFEKDK SEKEDKGKDI RESKK
//
